IPM Received Up to $25 Million To Accelerate Vaginal Ring Designed to Reduce HIV-1

The International Partnership for Microbicides (IPM) received up to $25 million throughout 5 years from the United States Agency for International Development to accelerate the potential rollout of its monthly dapivirine vaginal ring designed to reduce the risk of human immunodeficiency virus-1 (HIV) in HIV-negative women.
 

MD Magazine